… group” (TCZ group) included all patients who received standard treatment and tocilizumab (…
confirmed COVID-19 by SARS-CoV-2 RT-PCR or diagnosis confirmed during the tocilizumab …

… the role of Tocilizumab therapy (TCZ) in terms of ICU admission and mortality rate of critically
ill patients with severe COVID-19 pneumonia. Design: Patients with COVID-19 pneumonia …

… advocate the use of tocilizumab in selected cases of COVID-19 with progressive respiratory
failure and sustained inflammatory status despite dexamethasone therapy. Needless to say, …

… Greater inclusion of minorities and underserved populations in clinical trials of Covid-19
therapies is needed; these populations are often not a focus of trial recruitment and have been …

… COVID-19 Therapy [RECOVERY]), is assessing several possible treatments in patients
hospitalised with COVID-19 … <92% on air or requiring oxygen therapy) and evidence of systemic …

… Treatment Trial (ACTT-1) of remdesivir 34 became known during this trial, but the results of
the Randomized Evaluation of Covid-19 Therapy (RECOVERY) trial 35 regarding the efficacy …

… with mortality of COVID-19 patients.… tocilizumab therapy in patients with COVID-19 may be
associated with thrombotic events.To better analyse the efficacy and safety of tocilizumab, the …

… therapeutic role of tocilizumab in COVID-19 management. … effects of tocilizumab treatment
among COVID-19 patients, we … that patients with a tocilizumab treatment had better outcomes …

… COVID-19 as it highlights the RD in outcomes with addition of TOC in addition to other
therapies… One plausible rationale to this is the fact that the therapies for COVID-19 are rapidly …

… Therefore, we suggest that Tocilizumab is an effective treatment in severe patients of COVID-19
… for their contributions of this novel Tocilizumab therapeutic treatment towards COVID-19. …